NO20000285L - Terapeutisk eller profylaktisk middel for glomerulopati - Google Patents

Terapeutisk eller profylaktisk middel for glomerulopati

Info

Publication number: NO20000285L
Authority: NO; Norway
Prior art keywords: diyl; lower alkyl; thiophen; optionally substituted; phenyl
Prior art date: 1997-07-22

Application number

NO20000285A

Other languages

English (en)

Other versions

NO20000285D0 (no

Inventor

Hidetake Kurihara

Fumihiko Watanabe

Yoshinori Tamura

Toshihiro Sinosaki

Original Assignee

Shionogi & Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-22

Filing date

2000-01-20

Publication date

2000-03-22

2000-01-20 Application filed by Shionogi & Co filed Critical Shionogi & Co

2000-01-20 Publication of NO20000285D0 publication Critical patent/NO20000285D0/no

2000-03-22 Publication of NO20000285L publication Critical patent/NO20000285L/no

Links

208000022461 Glomerular disease Diseases 0.000 title abstract 2
230000000069 prophylactic effect Effects 0.000 title 1
230000001225 therapeutic effect Effects 0.000 title 1
-1 2,5-thiophendiyl Chemical group 0.000 abstract 10
125000000217 alkyl group Chemical group 0.000 abstract 7
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
125000004414 alkyl thio group Chemical group 0.000 abstract 3
125000003710 aryl alkyl group Chemical group 0.000 abstract 3
125000001475 halogen functional group Chemical group 0.000 abstract 3
125000001072 heteroaryl group Chemical group 0.000 abstract 3
125000000623 heterocyclic group Chemical group 0.000 abstract 3
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 3
125000003545 alkoxy group Chemical group 0.000 abstract 2
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 2
125000003118 aryl group Chemical group 0.000 abstract 2
125000004104 aryloxy group Chemical group 0.000 abstract 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
125000000753 cycloalkyl group Chemical group 0.000 abstract 2
125000002252 acyl group Chemical group 0.000 abstract 1
125000004423 acyloxy group Chemical group 0.000 abstract 1
125000003342 alkenyl group Chemical group 0.000 abstract 1
125000000304 alkynyl group Chemical group 0.000 abstract 1
125000000043 benzamido group Chemical group [H]N([*])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 abstract 1
125000001188 haloalkyl group Chemical group 0.000 abstract 1
125000004446 heteroarylalkyl group Chemical group 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000005415 substituted alkoxy group Chemical group 0.000 abstract 1
150000003456 sulfonamides Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
- C07C311/44—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
- C07C311/46—Y being a hydrogen or a carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/18—Radicals substituted by singly bound hetero atoms other than halogen by sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)
Enzymes And Modification Thereof (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20000285A 1997-07-22 2000-01-20 Terapeutisk eller profylaktisk middel for glomerulopati NO20000285L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP19541497		1997-07-22
PCT/JP1998/003226 WO1999004780A1 (en)	1997-07-22	1998-07-17	Therapeutic or prophylactic agent for glomerulopathy

Publications (2)

Publication Number	Publication Date
NO20000285D0 NO20000285D0 (no)	2000-01-20
NO20000285L true NO20000285L (no)	2000-03-22

Family

ID=16340702

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20000285A NO20000285L (no)	1997-07-22	2000-01-20	Terapeutisk eller profylaktisk middel for glomerulopati

Country Status (21)

Country	Link
US (2)	US6423729B1 (no)
EP (2)	EP1398027B1 (no)
JP (1)	JP3621427B2 (no)
KR (1)	KR100386148B1 (no)
CN (1)	CN1198607C (no)
AT (1)	ATE320801T1 (no)
AU (1)	AU737218B2 (no)
BR (1)	BR9811521A (no)
CA (1)	CA2297011C (no)
DE (2)	DE69833940T2 (no)
HU (1)	HUP0003851A3 (no)
ID (2)	ID24105A (no)
IL (1)	IL133933A0 (no)
NO (1)	NO20000285L (no)
NZ (1)	NZ502274A (no)
PL (1)	PL338235A1 (no)
RU (1)	RU2207849C2 (no)
SK (1)	SK262000A3 (no)
TR (2)	TR200000214T2 (no)
TW (2)	TWI249518B (no)
WO (1)	WO1999004780A1 (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SK262000A3 (en) *	1997-07-22	2001-01-18	Shionogi & Co	Therapeutic or prophylactic agent for glomerulopathy
EP1053226A1 (en)	1998-02-04	2000-11-22	Novartis AG	Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
US6410580B1 (en)	1998-02-04	2002-06-25	Novartis Ag	Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
WO2000015213A1 (en) *	1998-09-11	2000-03-23	Shionogi & Co., Ltd.	Remedal or preventive agent for congestive heart failure
US6495578B1 (en)	1999-04-19	2002-12-17	Shionogi & Co., Ltd.	Sulfonamide derivatives having oxadiazole rings
FR2798589B1 (fr) *	1999-09-16	2001-11-30	Oreal	Composition cosmetique comprenant au moins un copolymere silicone/acrylate et au moins un agent epaississant
US6727266B2 (en)	2000-01-26	2004-04-27	Shionogi & Co., Ltd.	Substituted tryptophan derivatives
AU2001248701A1 (en) *	2000-03-24	2001-10-03	Methylgene, Inc.	Inhibitors of histone deacetylase
JP3974781B2 (ja) *	2000-04-21	2007-09-12	塩野義製薬株式会社	抗癌作用を有するオキサジアゾール誘導体
AU2001248765A1 (en) *	2000-04-21	2001-11-12	Shionogi And Co., Ltd.	Oxadiazole derivatives having therapeutic or preventive efficacies against glomerular disorders
AU2001248820A1 (en) *	2000-04-28	2001-11-12	Shionogi And Co., Ltd.	Thiazole and oxazole derivatives
US6897237B2 (en)	2000-04-28	2005-05-24	Shionogi & Co. Ltd.	MMP-12 inhibitors
CA2423885A1 (en)	2000-09-29	2003-03-27	Shionogi & Co., Ltd.	Thiazole and oxazole derivatives
KR20050034603A (ko)	2001-10-09	2005-04-14	3-디멘져널 파마슈티칼즈 인코오포레이티드	치환된 디페닐옥사졸, 이의 합성 및 이의 형광프로브로서의 용도
EP1461313B1 (en) *	2001-12-14	2009-08-05	Exelixis, Inc.	Human adam-10 inhibitors
ATE429909T1 (de)	2002-05-29	2009-05-15	Merck & Co Inc	Nützliche verbindungen für die behandlung von anthrax und hemmung des letalen faktors
JPWO2005012268A1 (ja)	2003-07-30	2006-09-14	塩野義製薬株式会社	イソオキサゾール環を有するスルホンアミド誘導体
US7504431B2 (en) *	2004-04-16	2009-03-17	Bristol-Myers Squibb Company	Sulfonyl amide inhibitors of calcium channel function
JP2007537256A (ja)	2004-05-11	2007-12-20	メルク　エンド　カムパニー　インコーポレーテッド	Ｎ−スルホン化アミノ酸誘導体調製のためのプロセス
JP2006036691A (ja) *	2004-07-27	2006-02-09	Shionogi & Co Ltd	腎炎の治療または予防剤
US20080119513A1 (en) *	2004-09-06	2008-05-22	Fumihiko Watanabe	Sulfonamide Derivative Selectively Inhibiting Mmp-13
US7576222B2 (en)	2004-12-28	2009-08-18	Wyeth	Alkynyl-containing tryptophan derivative inhibitors of TACE/matrix metalloproteinase
JPWO2007102392A1 (ja)	2006-03-03	2009-07-23	塩野義製薬株式会社	Ｍｍｐ−１３選択的阻害剤
JPWO2008053913A1 (ja)	2006-11-02	2010-02-25	塩野義製薬株式会社	Ｍｍｐ−１３を選択的に阻害するスルホニルウレア誘導体
US8765953B2 (en) *	2008-12-23	2014-07-01	Aquilus Pharmaceuticals, Inc.	Compounds and methods for the treatment of pain and other diseases
AU2018317812C1 (en) *	2017-08-17	2021-08-26	Glaxosmithkline Intellectual Property Development Limited	Novel tetrazole compounds and their use in the treatment of tuberculosis

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH03204875A (ja) *	1989-10-03	1991-09-06	Wakamoto Pharmaceut Co Ltd	テトラゾール酢酸誘導体、及び該誘導体を有効成分とするアルドースレダクターゼ阻害剤
US5506242A (en)	1993-01-06	1996-04-09	Ciba-Geigy Corporation	Arylsufonamido-substituted hydroxamic acids
JP3818322B2 (ja) *	1994-04-28	2006-09-06	敏一中村	コラーゲン分解促進剤
NZ288299A (en)	1994-06-22	1998-06-26	British Biotech Pharm	Substituted (hetero)aryl-sulphonylaminomethyl-hydroxamic acid and medicaments
KR980009238A (ko)	1995-07-28	1998-04-30	우에노 도시오	설포닐아미노산 유도체
EP0757984B1 (en)	1995-08-08	2002-10-30	Ono Pharmaceutical Co., Ltd.	Hydroxamic acid derivatives useful for inhibiting gelatinase
CN1198096A (zh)	1995-08-08	1998-11-04	菲布洛根有限公司	用于治疗与胶原蛋白过量产生有关的疾病的c－蛋白酶抑制剂
JPH09110864A (ja) *	1995-08-10	1997-04-28	Kureha Chem Ind Co Ltd	クロモン誘導体、その製造方法及び医薬組成物
JPH0987178A (ja)	1995-09-22	1997-03-31	Toyama Chem Co Ltd	神経成長因子の作用増強剤
JPH0987176A (ja)	1995-09-26	1997-03-31	Shiseido Co Ltd	糸球体腎炎抑制剤
EP0950656B1 (en) *	1996-01-23	2007-04-11	Shionogi & Co., Ltd.	Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
CA2242416C (en) *	1996-01-23	2006-03-21	Shionogi & Co., Ltd.	Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
ATE207891T1 (de) *	1996-05-17	2001-11-15	Warner Lambert Co	Biphenylsulfonamid matrix metalloproteinase inhibitoren
JPH10265452A (ja) *	1996-05-24	1998-10-06	Ono Pharmaceut Co Ltd	フェニルスルホンアミド誘導体
WO1998003166A1 (en)	1996-07-22	1998-01-29	Monsanto Company	Thiol sulfonamide metalloprotease inhibitors
CA2285372A1 (en) *	1997-04-01	1998-10-08	Melwyn A. Abreo	Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
SK262000A3 (en) *	1997-07-22	2001-01-18	Shionogi & Co	Therapeutic or prophylactic agent for glomerulopathy

1998
- 1998-07-17 SK SK26-2000A patent/SK262000A3/sk unknown
- 1998-07-17 HU HU0003851A patent/HUP0003851A3/hu unknown
- 1998-07-17 ID IDW20000054A patent/ID24105A/id unknown
- 1998-07-17 DE DE69833940T patent/DE69833940T2/de not_active Expired - Lifetime
- 1998-07-17 EP EP03023547A patent/EP1398027B1/en not_active Expired - Lifetime
- 1998-07-17 KR KR10-2000-7000676A patent/KR100386148B1/ko not_active Expired - Fee Related
- 1998-07-17 EP EP98932574A patent/EP1029541B1/en not_active Expired - Lifetime
- 1998-07-17 WO PCT/JP1998/003226 patent/WO1999004780A1/ja not_active Ceased
- 1998-07-17 US US09/462,001 patent/US6423729B1/en not_active Expired - Fee Related
- 1998-07-17 PL PL98338235A patent/PL338235A1/xx unknown
- 1998-07-17 BR BR9811521-9A patent/BR9811521A/pt not_active Application Discontinuation
- 1998-07-17 AU AU82439/98A patent/AU737218B2/en not_active Ceased
- 1998-07-17 CA CA002297011A patent/CA2297011C/en not_active Expired - Fee Related
- 1998-07-17 TR TR2000/00214T patent/TR200000214T2/xx unknown
- 1998-07-17 ID IDW00200101551A patent/ID29293A/id unknown
- 1998-07-17 JP JP50964999A patent/JP3621427B2/ja not_active Expired - Fee Related
- 1998-07-17 CN CNB98809147XA patent/CN1198607C/zh not_active Expired - Fee Related
- 1998-07-17 TR TR2001/00389T patent/TR200100389T2/xx unknown
- 1998-07-17 DE DE69836877T patent/DE69836877D1/de not_active Expired - Lifetime
- 1998-07-17 NZ NZ502274A patent/NZ502274A/xx unknown
- 1998-07-17 AT AT98932574T patent/ATE320801T1/de not_active IP Right Cessation
- 1998-07-17 IL IL13393398A patent/IL133933A0/xx unknown
- 1998-07-17 RU RU2000103032/04A patent/RU2207849C2/ru not_active IP Right Cessation
- 1998-09-30 TW TW092118405A patent/TWI249518B/zh not_active IP Right Cessation
- 1998-09-30 TW TW087111798A patent/TW593249B/zh not_active IP Right Cessation
2000
- 2000-01-20 NO NO20000285A patent/NO20000285L/no not_active Application Discontinuation
2002
- 2002-06-06 US US10/162,865 patent/US6878739B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
HUP0003851A2 (hu)	2001-07-30
AU8243998A (en)	1999-02-16
EP1029541A4 (en)	2000-08-23
BR9811521A (pt)	2000-08-22
TW200400934A (en)	2004-01-16
KR100386148B1 (ko)	2003-06-02
ID29293A (id)	1999-01-28
CN1270518A (zh)	2000-10-18
TR200100389T2 (tr)	2001-08-21
WO1999004780A1 (en)	1999-02-04
DE69836877D1 (de)	2007-02-22
TWI249518B (en)	2006-02-21
IL133933A0 (en)	2001-04-30
TR200000214T2 (tr)	2000-09-21
DE69833940D1 (de)	2006-05-11
JP3621427B2 (ja)	2005-02-16
TW593249B (en)	2004-06-21
CA2297011C (en)	2007-01-30
SK262000A3 (en)	2001-01-18
US6878739B2 (en)	2005-04-12
US20030078434A1 (en)	2003-04-24
RU2207849C2 (ru)	2003-07-10
EP1029541A1 (en)	2000-08-23
NZ502274A (en)	2001-03-30
AU737218B2 (en)	2001-08-09
ID24105A (id)	2000-07-06
KR20010022106A (ko)	2001-03-15
EP1398027B1 (en)	2007-01-10
CN1198607C (zh)	2005-04-27
DE69833940T2 (de)	2006-12-14
EP1398027A1 (en)	2004-03-17
EP1029541B1 (en)	2006-03-22
US6423729B1 (en)	2002-07-23
PL338235A1 (en)	2000-10-09
NO20000285D0 (no)	2000-01-20
ATE320801T1 (de)	2006-04-15
CA2297011A1 (en)	1999-02-04
HUP0003851A3 (en)	2002-10-28

Legal Events

Date	Code	Title	Description
2005-05-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20000285D0 (no)	2000-01-20	Terapeutisk eller profylaktisk middel for glomerulopati
HUT43238A (en)	1987-10-28	Herbicidal compositions comprising substituted piridine-sulfonamide derivatives as active substance and process for preparing the active substances
ATE369337T1 (de)	2007-08-15	Neue bizyklische verbindungen
BR0014651A (pt)	2002-06-18	Inibidores de adesão de célula mediada por "alfa" l beta2
JP2002508362A5 (ja)	2006-01-05	１−置換−１−アミノメチル−シクロアルカン誘導体（＝ガバペンチン類縁体）
ES2191356T3 (es)	2003-09-01	Compuestos heterociclicos para la inhibicion de la secrecion de acidos gastricos, procedimientos para su preparacion y composiciones farmaceuticas de ellos.
ID28806A (id)	2001-07-05	Turunan-turunan karboksamida heterosiklik yang mengandung nitrogen atau garam-garam daripadanya dan zat-zat antivirus yang terdiri dari senyawa ini
NO990673L (no)	1999-04-15	Purinderivater og deres anvendelse som antikoagulanter
DK0976748T3 (da)	2004-03-22	Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet
ATE271868T1 (de)	2004-08-15	Neue cathechole als antimikrobielle mittel
NO20014925L (no)	2001-12-13	Farmasöytiske forbindelser
ES2182054T3 (es)	2003-03-01	Derivados de oxazol, su produccion y uso.
DE60005689D1 (de)	2003-11-06	Neue aminobenzophenone
ATE233104T1 (de)	2003-03-15	Kondensierte imidazolderivate zur erhöhung der oralen bioverfügbarkeit von pharmazeutika
PT1709027E (pt)	2010-01-13	Compostos do tipo hidrazida e sua utilização em composições farmacêuticas para o tratamento de doenças cardiovasculares
ATE274508T1 (de)	2004-09-15	Aminophenolderivate
DE60013515D1 (de)	2004-10-14	4-Arylpiperidinderivate zur Behandlung von Pruritus
RU2002101136A (ru)	2003-09-10	Средства для лечения и профилактики неоплазм
BR9916366A (pt)	2001-09-18	Derivados de 6-azauracila, inibidores de il-5
WO2002088091A3 (en)	2002-12-19	Inhibitors of human rhinovirus 2a cysteine protease
DE60208554D1 (de)	2006-03-30	Neue aliphatische verbindung, syntheseverfahren und anwendungsverfahren
DE69904051D1 (de)	2003-01-02	Zubereitung enthaltend derivate von phenylaminothiophenessigsäure zur behandlung der akuten respiratorischen insuffizienz (ards) und der akuten respiratorischen insuffizienz bei kindern (irds)
MXPA01011888A (es)	2002-06-21	Derivados de tetrazolinona.
NO20051774L (no)	2005-05-10	Taksanderivater funksjonalisert pa den 14.posisjon og en fremgangsmate for fremstilling derav
ATE223406T1 (de)	2002-09-15	1,4-disubstitutierte cyclohexanderivate zur behandlung von depression